Tim McCarthy talks to Proactive Investors – 6th February 2017
6th February 2017 - 4:24 pmTim McCarthy, chairman of ImmuPharma PLC (LON:IMM) spoke to Proactive Investors to give an update on the company’s progress with its phase-III clinical trial of Lupuzor™, a treatment for Lupus – a life threatening auto-immune disease.